Enovis Surges on Favorable Rating, Still Below 52-Week High
Update: 2025-12-17
Description
Enovis Corporations shares surged nearly seven percent following Freedom Capital Markets Buy rating and a price target of forty-five dollars, suggesting a potential seventy percent upside. The firm praised Enoviss Reconstructive surgical business, projected to account for half of its sales in 2025. Despite todays rally, Enovis is still down thirty-eight percent year-to-date, trading at twenty-seven dollars and forty-eight cents per share.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
